The groundbreaking approach of this peptide represents a significant breakthrough in the care of type 2 diabetes. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide508183.actoblog.com/42967524/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment